Will Minerva Neurosciences Inc (NERV) Beat the Rest of the Stocks in the Healthcare Sector?

A rating of 57 puts Minerva Neurosciences Inc (NERV) near the top of the Healthcare sector according to InvestorsObserver. Minerva Neurosciences Inc's score of 57 means that it ranks higher than 57% of stocks in the sector. In addition, its overall score of 23 ranks it higher than 23% of all stocks.

NERV has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on NERV!

See Full NERV Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Minerva Neurosciences Inc Stock Today?

Minerva Neurosciences Inc (NERV) stock is trading at $2.87 as of 10:45 AM on Thursday, Feb 29, an increase of $0.04, or 1.33% from the previous closing price of $2.83. The stock has traded between $2.82 and $3.03 so far today. Volume today is less active than usual. So far 60,707 shares have traded compared to average volume of 166,313 shares. Click Here to get the full Stock Report for Minerva Neurosciences Inc stock.